144 related articles for article (PubMed ID: 16906883)
21. [Angiogenesis and endothelial cells in blood neoplasms].
Usnarska-Zubkiewicz L; Poreba M; Kuliczkowski K
Przegl Lek; 2006; 63(3):146-50. PubMed ID: 16969900
[TBL] [Abstract][Full Text] [Related]
22. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.
Plank MJ; Sleeman BD; Jones PF
J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783
[TBL] [Abstract][Full Text] [Related]
23. Dynamical model for assessment of anti-angiogenic therapy of cancer.
Mukherjee A; Majumder D
Mol Biosyst; 2010 Jun; 6(6):1047-55. PubMed ID: 20358121
[TBL] [Abstract][Full Text] [Related]
24. Molecular heterogeneity of tumor endothelium.
Aird WC
Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cell heterogeneity.
Aird WC
Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a006429. PubMed ID: 22315715
[TBL] [Abstract][Full Text] [Related]
26. Potential therapeutic implications of intracrine angiogenesis.
Re RN; Cook JL
Med Hypotheses; 2007; 69(2):414-21. PubMed ID: 17320306
[TBL] [Abstract][Full Text] [Related]
27. Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999).
d'Onofrio A; Gandolfi A
Math Biosci; 2004 Oct; 191(2):159-84. PubMed ID: 15363652
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
29. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
[No Abstract] [Full Text] [Related]
30. Angiogenesis as a target for tumor treatment.
Gastl G; Hermann T; Steurer M; Zmija J; Gunsilius E; Unger C; Kraft A
Oncology; 1997; 54(3):177-84. PubMed ID: 9143396
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of the Influence of Angiogenesis on Tumor Growth with the Use of a Mathematical Model].
Kolobov AV; Kuznetsov MB
Biofizika; 2015; 60(3):555-63. PubMed ID: 26349221
[TBL] [Abstract][Full Text] [Related]
32. A 2D mathematical model for tumor angiogenesis: The roles of certain cells in the extra cellular matrix.
Pamuk S; Çay İ; Sazcı A
Math Biosci; 2018 Dec; 306():32-48. PubMed ID: 30393207
[TBL] [Abstract][Full Text] [Related]
33. Engineered human tumor xenografts with functional human vascular networks.
Alonso-Camino V; Santos-Valle P; Ispizua MC; Sanz L; Alvarez-Vallina L
Microvasc Res; 2011 Jan; 81(1):18-25. PubMed ID: 20934439
[TBL] [Abstract][Full Text] [Related]
34. Targeting tumor vasculature: reality or a dream?
Satchi-Fainaro R
J Drug Target; 2002 Nov; 10(7):529-33. PubMed ID: 12683719
[No Abstract] [Full Text] [Related]
35. Continuous and discrete mathematical models of tumor-induced angiogenesis.
Anderson AR; Chaplain MA
Bull Math Biol; 1998 Sep; 60(5):857-99. PubMed ID: 9739618
[TBL] [Abstract][Full Text] [Related]
36. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
Olaso E; Vidal-Vanaclocha F
Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
[No Abstract] [Full Text] [Related]
37. Anti-angiogenic therapies in cancer: achievements and open questions.
Ruegg C; Mutter N
Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
[TBL] [Abstract][Full Text] [Related]
38. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
[TBL] [Abstract][Full Text] [Related]
39. Roles of main pro- and anti-angiogenic factors in tumor angiogenesis.
Huang Z; Bao SD
World J Gastroenterol; 2004 Feb; 10(4):463-70. PubMed ID: 14966899
[TBL] [Abstract][Full Text] [Related]
40. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
Werther K; Nielsen HJ
Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
